Argonautica Private Wealth Management’s Pfizer PFE Stock Holding History

Argonautica Private Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-44,922	Closed	-$1.65M	–	192
2023 Q2	$1.65M	Buy	44,922 +843	+2%	+$32.8K	0.74%	44
2023 Q1	$1.8M	Sell	44,079 -17,123	-28%	-$740K	0.91%	38
2022 Q4	$3.14M	Buy	+61,202	New	+$2.93M	1.61%	15

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Argonautica Private Wealth Management's PFE Position: Q3 2023 in Review

Argonautica Private Wealth Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 44,922 shares — an estimated $1.65M sold.

Argonautica Private Wealth Management first reported a position in PFE in Q4 2022 and held it in 3 quarters. The position peaked at $3.14M in Q4 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Argonautica Private Wealth Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Argonautica Private Wealth Management sold 44,922 Pfizer shares in Q3 2023, an estimated $1.65M.
Argonautica Private Wealth Management first reported a position in Pfizer in Q4 2022 and held it in 3 quarters.
Argonautica Private Wealth Management's Pfizer position peaked at $3.14M in Q4 2022.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Argonautica Private Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.